Nursing Care and ECMO explores the unique aspects involved in the management of ECMO patients such as physiopathology and indications, setting up the device, monitoring ECMO and the patient, troubleshooting, ethical aspects and rehabilitation. For the past eight years, management of acute heart failure and Acute Respiratory Distress Syndrome (ARDS) patients has been improved by the development of short-term assistance devices, with ECMO as a first line treatment.
Nursing Care and ECMO provides essential insights for ICU nurses at ECMO centers around the world, who face the substantial challenges involved in the management of ECMO patients. Above all, Nursing Care and ECMO meets their training needs with regard to bedside monitoring for these patients, which has become a major issue. The editors and most of the contributors serve at La Pitié-Salpétrière ICU, France, which, in terms of the number of admissions and major publications produced, is one of the world’s leading authorities on ECMO.
About the Author
Chirine Mossadegh has been a registered nurse for the past ten years in the ICU at La Pitié-Salpetrière Hospital in Paris, France. She has been a member of the organizing committee of the annual international congress for the French ICU society from 2010 to 2014.
She is the nurse’s program coordinator for the International Congress on ECMO and short term circulatory/respiratory support taking place every June in Paris for the past 5 years. She’s also teaching about nursing care and ECMO for the French university diploma on ECMO since its creation in 2012 and for the la Pitié Hospital International diploma in ECMO and short term respiratory/circulatory support since its creation in 2014.
Prof. Alain Combes is currently Professor of Critical Care Medicine at, Hôpital Pitié-Salpétrière, Université de Paris 6 since 2007.His interest research are: Care of patients with severe/refractory cardiac and/or respiratory failure, Paris ECMO center- VA ECMO, LVADs, heart transplantation for end-stage cardiac failure- VV ECMO, ECCO2R for severe respiratory failure Primary investigator of 3 multicenter international randomized trial:- EOLIA, to test the impact of early ECMO treatment in severe ARDS- HEROICS, to test high volume hemofiltration in patients with complicated heart surgery- SUPERNOVA, ECCO2R for moderate to severe ARDS
He is a regular reviewer for the following journals : – American Journal of Respiratory and Critical Care Medicine, Circulation, JACC, Lancet respiratory, Critical Care Medicine, Chest, Cochrane library, Intensive Care Medicine, BMJ, Heart, Critical Care, Journal of Critical Care, Expert Opinion on Pharmacotherapy, La Presse Médicale. He has published 108 peer-reviewed articles.